You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Entecavir

Showing 1 - 25 of 358
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Chronic Trial in Seoul (Vemliver tablet, Entecavir Tablet)

Recruiting
  • Hepatitis B, Chronic
  • Vemliver tablet
  • Entecavir Tablet
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)

Enrolling by invitation
  • Hepatitis B Reactivation
  • +3 more
  • Entecavir
  • Seoul, Korea, Republic of
    Jeong Won Jang
Dec 16, 2022

Chronic Hepatitis B Trial in Shatin (Tenofovir alafenamide, Entecavir)

Not yet recruiting
  • Chronic Hepatitis B
  • Tenofovir alafenamide
  • Entecavir
  • Shatin, Hong Kong
    Prince of Wales Hospital
Jun 15, 2022

Resolved Hepatitis B, CD20 Positive B-cell Lymphoma Trial (Entecavir)

Not yet recruiting
  • Resolved Hepatitis B
  • CD20 Positive B-cell Lymphoma
  • Entecavir
  • (no location specified)
Jul 10, 2022

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Ropeginterferon alfa-2b
  • Entecavir
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Hepatocellular Carcinoma, Chronic Hepatitis B Trial in Xiamen (NAs("Entecavir"or"Tenofovir"or"Tenofovir alafenamide") combined

Recruiting
  • Hepatocellular Carcinoma
  • Chronic Hepatitis B
  • NAs（"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） combined with interferon treatments
  • NAs （"Entecavir"or"Tenofovir"or"Tenofovir alafenamide"） treatments
  • Xiamen, Fujian, China
    Boheng Zhang
Feb 7, 2023

Hepatocellular Carcinoma Trial in Nanning (Entecavir, Tenofovir)

Recruiting
  • Hepatocellular Carcinoma
  • Nanning, Guangxi, China
    Department of Hepatobilliary Surgery, Affiliated Tumor of Guangx
Jan 14, 2022

Hepatitis B, Viral Hepatitis Trial in Taichung (Tenofovir alafenamide, Entecavir)

Recruiting
  • Hepatitis B
  • Viral Hepatitis
  • Tenofovir alafenamide
  • Entecavir
  • Taichung, Taiwan
    Taichung Veterans General Hospital
Feb 9, 2022

Antiviral Drugs Trial in Changsha (tenofovir alafenamide, Entecavir)

Completed
  • Antiviral Drugs
  • tenofovir alafenamide
  • Entecavir
  • Changsha, China
    Wenting Peng
Jul 10, 2022

Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Entecavir
  • Entecavir combined with Tenofovir Amibufenamide
  • Guangzhou, Guangdong, China
    The Third Affiliated Hospital of Sun Yat-sen University
May 15, 2022

Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

Recruiting
  • Lung Transplant
  • Hepatitis B
  • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
  • Philadelphia, Pennsylvania
    Hospital of University of Pennsylvania
Oct 1, 2022

Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B

Not yet recruiting
  • Patient Satisfaction
  • +3 more
  • tenofovir alafenamide (TAF)
  • (no location specified)
Oct 15, 2022

Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)

Recruiting
  • Hepatitis B, Chronic
  • ASC42 10mg
  • +4 more
  • Guangzhou, Guangdong, China
    NanFang Hospital of Southern Medical University
Jan 13, 2022

Hepatitis D Trial in Athens (Bulevirtide)

Recruiting
  • Hepatitis D
  • Athens, Greece
    Department of Gastroenterology, Medical School of National & Kap
Jun 28, 2023

Hepatitis B, Chronic Hep B, HBV Trial in Guangzhou, Shanghai, Chengdu (APG-1387, Entecavir 0.5 mg)

Recruiting
  • Hepatitis B
  • +2 more
  • Guangzhou, Guangdong, China
  • +3 more
Aug 25, 2021

Chronic Hepatitis B Trial in Tai'an (Metformin & Entecavir, Placebo & Entecavir)

Completed
  • Chronic Hepatitis B
  • Metformin & Entecavir
  • Placebo & Entecavir
  • Tai'an, Shandong, China
    The 960th Hospital of Chinese PLA Joint Logistics Support Force
Nov 23, 2021

Entecavir Versus Tenofovir on HBV DNA Level in Peripheral Blood

Not yet recruiting
  • Hepatitis B, Chronic
  • Detection of HBV-DNA in Peripheral Blood Mononuclear cells
  • (no location specified)
Dec 13, 2021

Hepatitis B, Chronic Trial in Shanghai, Beijing (Hydronidone, Placebo, Entecavir)

Completed
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
  • +1 more
Jun 21, 2022

Healthy, Hepatitis B, Chronic Trial in Grafton (JNJ-64457744, Placebo, Tenofovir Disoproxil Fumarate (TDF))

Recruiting
  • Healthy
  • Hepatitis B, Chronic
  • Grafton, New Zealand
    New Zealand Clinical Research
Aug 11, 2022

Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

Active, not recruiting
  • Chronic Hepatitis b
  • Nuc Discontinuation
  • Entecavir or Tenofovir
  • Chiayi City, Taiwan
  • +5 more
Mar 30, 2023

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Cirrhosis, Liver, Metagonimiasis Trial in Hangzhou (Entecavir 0.5 mg, A 10-g packet of lactulose oral solution and three

Completed
  • Cirrhosis, Liver
  • Metagonimiasis
  • Entecavir 0.5 mg
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jan 12, 2023

Liver Fibrosis Trial in Beijing, Shanghai (Hydronidone capsules, The capsules)

Recruiting
  • Liver Fibrosis
  • Hydronidone capsules
  • The placebo capsules
  • Beijing, Beijing, China
  • +1 more
Mar 31, 2022

Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

Terminated
  • Hepatitis B, Chronic
  • Granulocyte Macrophage-colony Stimulating Factor
  • Entecavir
  • Beijing, Beijing, China
    302 Military Hospital
Mar 9, 2022

HCC, HBV Coinfection Trial in Chengdu (Tenofovir Disoproxil, Entecavir)

Active, not recruiting
  • HCC
  • HBV Coinfection
  • Tenofovir Disoproxil
  • Entecavir
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
May 23, 2022